ViiV Healthcare to triple annual supply of long─acting HIV PrEP for low─ and middle─income countries
GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has shared the company’s commitment to make at least two million doses of long-acting cabotegravir for HIV pre- …